✦ LIBER ✦

Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide

✍ Scribed by Yuka Sugimoto; Mikkael A Sekeres; Hideki Makishima; Fabiola Traina; Valeria Visconte; Anna Jankowska; Andres Jerez; Hadrian Szpurka; Christine L O’Keefe; Kathryn Guinta; Manuel Afable; Ramon Tiu; Kathy L McGraw; Alan F List; Jaroslaw Maciejewski

Book ID: 115025385
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 262 KB
Volume: 5
Category: Article
ISSN: 1756-8722
DOI: 10.1186/1756-8722-5-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to lenalidomide in myelodysplas

Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations

✍ Mallo, Mar; del Rey, Mónica; Ibáñez, Mariam; Calasanz, Mª José; Arenillas, Leono 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

Hematologic and cytogenetic response to

Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion

✍ Maria J. Peñarrubia; Luz A. Silvestre; Joaquina Conde; Alberto Cantalapiedra; Lu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 150 KB

P-012 Clonal activation of Akt in low-ri

P-012 Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide

✍ Follo, M.Y.; Mongiorgi, S.; Clissa, C.; Stoyanova, M.; Paolini, S.; Quaranta, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Extended survival and reduced risk of AM

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS

✍ List, A F; Bennett, J M; Sekeres, M A; Skikne, B; Fu, T; Shammo, J M; Nimer, S D 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 440 KB

Response to lenalidomide in patients wit

Response to lenalidomide in patients with myelodysplastic syndrome with deletion 5q: clinical and cytogenetic analysis of a single centre series

✍ Rita Coutinho; Dolors Costa; Ana Carrió; Concha Muñoz; Ana Vidal; Mohammed Belka 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 64 KB

Haematological and cytogenetic responses

Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion

✍ Sondes Hadiji Mseddi; Faten Kallel; Olfa Kassar; Moez Elloumi; Ines Jedidi; Hali 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 111 KB